Cover Image

Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection

Shyam A. Patel, Karim Y. Helmy, Meneka A. Dave, Raghav G. Murthy, Pranela Rameshwar
  • Shyam A. Patel
    Division of Hematology/Oncology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, United States | rameshwa@umdnj.edu
  • Karim Y. Helmy
    Division of Hematology/Oncology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, United States
  • Meneka A. Dave
    Division of Hematology/Oncology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, United States
  • Raghav G. Murthy
    Division of Hematology/Oncology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, United States
  • Pranela Rameshwar
    Division of Hematology/Oncology, Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, United States

Abstract

Among all cancers, malignancies of the breast are the second leading cause of cancer death in the United States after carcinoma of the lung. One of the major factors considered when assessing the prognosis of breast cancer patients is whether the tumor has metastasized to distant organs. Although the exact phenotype of the malignant cells responsible for metastasis and dormancy is still unknown, growing evidence has revealed that they may have stem cell-like properties that may account for resistance to chemotherapy and radiation. One process that has been attributed to primary tumor metastasis is the epithelial- to-mesenchymal transition. In this review, we specifically discuss breast cancer dissemination to the bone marrow and factors that ultimately serve to shelter and promote tumor growth, including the complex relationship between mesenchymal stem cells (MSCs) and various aspects of the immune system, carcinoma-associated fibroblasts, and the diverse components of the tumor microenvironment. A better understanding of the journey from the primary tumor site to the bone marrow and subsequently the oncoprotective role of MSCs and other factors within that microenvironment can potentially lead to development of novel therapeutic targets.

Keywords

Oncoprotection - Cancer stem cell - Microenvironment - Metastasis

Full Text:

FULL TEXT
Submitted: 2011-11-30 11:26:12
Published: 2011-06-30 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
600

Views:
FULL TEXT
153

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2011 Shyam A. Patel, Karim Y. Helmy, Meneka A. Dave, Raghav G. Murthy, Pranela Rameshwar

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185